Aviv REIT Inc (AVIV) Financial Statements (2024 and earlier)
Company Profile
Business Address |
303 W. MADISON ST. CHICAGO, IL 60606 |
State of Incorp. | MD |
Fiscal Year End | December 31 |
Industry (SIC) | 6798 - Real Estate Investment Trusts (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2014 | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 50,764 | 17,876 | |||
Cash and cash equivalents | 50,764 | 17,876 | |||
Total current assets: | 50,764 | 17,876 | |||
Noncurrent Assets | |||||
Property, plant and equipment | 168,743 | 131,215 | |||
Long-term investments and receivables | 41,700 | 32,600 | |||
Accounts and financing receivable, after allowance for credit loss | 41,700 | 32,600 | |||
Intangible assets, net (including goodwill) | 4 | 4,248 | |||
Intangible assets, net (excluding goodwill) | 4 | 4,248 | |||
Deferred costs | 3,685 | 4,248 | |||
Total noncurrent assets: | 214,132 | 172,311 | |||
Other undisclosed assets | 1,065,537 | 909,341 | |||
TOTAL ASSETS: | 1,330,433 | 1,099,529 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Noncurrent Liabilities | |||||
Other undisclosed liabilities | 761,988 | 779,026 | |||
Total liabilities: | 761,988 | 779,026 | |||
Equity | |||||
Equity, attributable to parent | 434,292 | 326,568 | |||
Common stock | 376 | 4 | |||
Additional paid in capital | 523,658 | 375,243 | |||
Accumulated other comprehensive loss | (2,152) | ||||
Accumulated deficit | (89,742) | (46,527) | |||
Equity, attributable to noncontrolling interest | (6,065) | ||||
Other undisclosed equity | 134,153 | ||||
Total equity: | 568,445 | 320,502 | |||
TOTAL LIABILITIES AND EQUITY: | 1,330,433 | 1,099,529 |
Income Statement (P&L) ($ in thousands)
12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Revenues | 141,067 | 123,172 | ||
Revenue, net | 136,513 | 117,410 | ||
Cost of revenue | (89,183) | (89,436) | ||
Gross profit: | 51,884 | 33,736 | ||
Operating expenses | (28,813) | (29,729) | ||
Other operating income, net (Other Expenses) | 400 | |||
Operating income: | 23,071 | 4,407 | ||
Interest and debt expense | (51,759) | (51,011) | ||
Loss from continuing operations before equity method investments, income taxes: | (28,688) | (46,604) | ||
Other undisclosed income from continuing operations before income taxes | 50,359 | |||
Income (loss) from continuing operations before income taxes: | 21,671 | (46,604) | ||
Other undisclosed income from continuing operations | 1,400 | 50,611 | ||
Income from continuing operations: | 23,071 | 4,007 | ||
Income before gain (loss) on sale of properties: | 23,071 | 8,593 | ||
Income from discontinued operations | 4,587 | |||
Net income: | 23,071 | 8,593 | ||
Net loss attributable to noncontrolling interest | (6,010) | (3,455) | ||
Net income available to common stockholders, basic: | 17,061 | 5,138 | ||
Other undisclosed net income available to common stockholders, diluted | 4,610 | |||
Net income available to common stockholders, diluted: | 21,671 | 5,138 |
Comprehensive Income ($ in thousands)
12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Net income: | 23,071 | 8,593 | ||
Other undisclosed comprehensive loss | (476) | |||
Comprehensive income: | 23,071 | 8,117 | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 6,010 | 3,455 | ||
Other undisclosed comprehensive loss, net of tax, attributable to parent | (12,020) | (6,718) | ||
Comprehensive income, net of tax, attributable to parent: | 17,061 | 4,854 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.